BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND ESR1, ESR, 2099, ENSG00000091831, RP1-130E4_1, NR3A1, ESRA, DKFZp686N23123, ER, Era AND Treatment
15108 results:

  • 1. Immunotherapy in the neoadjuvant treatment of gastrointestinal tumors: is the time ripe?
    Gervaso L; Ciardiello D; Oliveira RA; Borghesani M; Guidi L; Benini L; Algeri L; Spada F; Zampino MG; Cella CA; Fazio N
    J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38782539
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Premature mortality for patients after completely resected early adenocarcinoma of the esophagus or stomach.
    Bollschweiler E; Hölscher AH; Markar SR; Alakus H; Drebber U; Mönig SP; Plum PS
    Cancer Med; 2024 May; 13(10):e7223. PubMed ID: 38778711
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Trends, challenges, and reflections on early-onset gastric cancer].
    Wang XF; Sun YH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 May; 27(5):425-429. PubMed ID: 38778679
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. gastric cancer immune microenvironment score predicts neoadjuvant chemotherapy efficacy and prognosis.
    Zhao S; Liu Y; Ding L; Zhang C; Ye J; Sun K; Song W; Cai S; He Y; Peng J; Xu J
    J Pathol Clin Res; 2024 May; 10(3):e12378. PubMed ID: 38778559
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical biomarkers for thyroid immune-related adverse events in patients with stage III and IV gastrointestinal tumors.
    Xing N; Liu J; Hou L; Zhao Y; Ma H; Wang F; Guo Z
    Front Immunol; 2024; 15():1381061. PubMed ID: 38774877
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. An On-treatment Decreased Trend of Serum IL-6 and IL-8 as Predictive Markers Quickly Reflects Short-Term Efficacy of PD-1 Blockade Immunochemotherapy in Patients with Advanced gastric cancer.
    Liu J; Mao Y; Mao C; Wang D; Dong L; Zhu W
    J Immunol Res; 2024; 2024():3604935. PubMed ID: 38774604
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. State-of-the-Art Advancements in Gastroesophageal cancer treatment: Harnessing Biomarkers for Precision Care.
    Balmaceda NB; Petrillo A; Krishnan M; Zhao JJ; Kim S; Klute KA; Sundar R
    Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e431060. PubMed ID: 38771996
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Impact of the number of therapy lines on survival in advanced gastric and esophagogastric adenocarcinoma - a real-world retrospective analysis from Croatia.
    Bišof V; Katić A; Soče M; Vidović M; Viculin J; Pleština S; Vrdoljak E
    Neoplasma; 2024 Apr; 71(2):201-208. PubMed ID: 38766850
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Fertility preservation in female cancer patients in Brazil: perceptions and attitudes of infertility specialists.
    Ranniger RL; Lamaita RM; D'Abreu BF; Tolentino MR; Cândido EB; Andrade WP; Nogueira-Rodrigues A; Silva-Filho AL
    Rev Bras Ginecol Obstet; 2024; 46():. PubMed ID: 38765513
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clip-and-snare method with a pre-looping technique versus conventional method in the treatment of precancerous lesion and early gastric cancer: a retrospective study.
    Deng R; Wu J; Li D; Wu B; Shi R; Tian Y; Yao J; Wang LS
    BMC Gastroenterol; 2024 May; 24(1):170. PubMed ID: 38760726
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A humanized trivalent Nectin-4-targeting nanobody drug conjugate displays potent antitumor activity in gastric cancer.
    Wu Y; Zhu M; Sun B; Chen Y; Huang Y; Gai J; Li G; Li Y; Wan Y; Ma L
    J Nanobiotechnology; 2024 May; 22(1):256. PubMed ID: 38755613
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The optimal threshold of PD-L1 combined positive score to predict the benefit of PD-1 antibody plus chemotherapy for patients with HER2-negative gastric adenocarcinoma: a meta-analysis.
    Li JB; Lai MY; Lin ZC; Guan WL; Sun YT; Yang J; Wang WX; Yang ZR; Qiu MZ
    Cancer Immunol Immunother; 2024 May; 73(7):132. PubMed ID: 38753055
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2-Positive Advanced gastric cancer.
    Yamaguchi K; Ito M; Isobe T; Koreishi S; Taguchi R; Uehara K; Ueno S; Imajima T; Kitazono T; Tsuchihashi K; Ohmura H; Yoshihiro T; Tanoue K; Nishiyori S; Iwama E; Maeda T; Akashi K; Baba E
    JCO Precis Oncol; 2024 May; 8():e2300681. PubMed ID: 38748981
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Clinical characteristics and prognosis analysis of gastric cancer patients with bone metastasis].
    Zhang MM; Lai M; Li YT; An Y; Yuan WZ
    Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):438-448. PubMed ID: 38742357
    [No Abstract]    [Full Text] [Related]  

  • 15. Nutritional responsiveness affects novel neutrophil parameters and reduces in-hospital mortality and costs in elective cancer oesophagectomy - a single centre, prospective, observational study.
    Kutnik P; Borys M; Nurczyk K; Domerecka W; Dziedzic J; Buszewicz G; Teresiński G; Donica H; Piwowarczyk P; Czuczwar M
    Anaesthesiol Intensive Ther; 2024; 56(1):77-82. PubMed ID: 38741447
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Evaluation of the cytotoxic activities of the essential oil from Pistacia atlantica Desf. oleoresin on human gastric cancer cell lines.
    Saeedi F; Salehi M; Kamali MJ; Mir MA; Kazemi S; Shirafkan F; Neyshaburi EZ; Moeeni R; Gorji N; Memariani Z
    Med Oncol; 2024 May; 41(6):148. PubMed ID: 38733486
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. An In Vitro Study on the Cytotoxic, Antioxidant, and Antimicrobial Properties of Yamogenin-A Plant Steroidal Saponin and Evaluation of Its Mechanism of Action in gastric cancer Cells.
    Stefanowicz-Hajduk J; Graczyk P; Hering A; Gucwa M; Nowak A; Hałasa R
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731847
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinical features of patients with carcinoma soft tissue metastases as surgical indications: a retrospective cohort study.
    Morinaga S; Yamamoto N; Hayashi K; Takeuchi A; Miwa S; Igarashi K; Taniguchi Y; Asano Y; Nojima T; Tsuchiya H
    BMC Cancer; 2024 May; 24(1):577. PubMed ID: 38730358
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Toxicity of immunotherapy combinations with chemotherapy across tumor indications: Current knowledge and practical recommendations.
    Rached L; Laparra A; Sakkal M; Danlos FX; Barlesi F; Carbonnel F; De Martin E; Ducreux M; Even C; Le Pavec J; Michot JM; M Ribeiro J; Scotte F; Ponce Aix S; Lambotte O; Baldini C; Champiat S
    Cancer Treat Rev; 2024 Jun; 127():102751. PubMed ID: 38729086
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The influence of delayed gastric emptying on quality of life after partial duodenopancreatectomy.
    Klein M; Warschkow R; Ukegjini K; Krstic D; Burri P; Chatziisaak D; Steffen T; Schmied B; Probst P; Tarantino I
    Langenbecks Arch Surg; 2024 May; 409(1):155. PubMed ID: 38727871
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 756.